There is a newer version of this record available.

Preprint Open Access

An open letter to Oran and Topol, and the Annals of Internal Medicine

Muge Cevik; Isaac I Bogoch; Gail Carson; Eric D'Ortenzio; Krutika Kuppali; Nicola Low; Sara Loree; Alasdair Munro; Lina Moses; Harish Nair; Piero Olliaro; Louise Sigfrid; Renaud Vatrinet; on behalf of the CORRE Network (International COVID-19 Rapid Evidence Reviews Group)


DCAT Export

<?xml version='1.0' encoding='utf-8'?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#">
  <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.3888361">
    <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/>
    <dct:type rdf:resource="http://purl.org/dc/dcmitype/Text"/>
    <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.3888361</dct:identifier>
    <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.3888361"/>
    <dct:creator>
      <rdf:Description rdf:about="http://orcid.org/0000-0003-1133-3874">
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">0000-0003-1133-3874</dct:identifier>
        <foaf:name>Muge Cevik</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>1Division of Infection and Global Health Research, School of Medicine, University of St Andrews, UK</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Isaac I Bogoch</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>2Division of Infectious Diseases, Toronto General Hospital and University of Toronto, Canada</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Gail Carson</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>3 ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Eric D'Ortenzio</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>4INSERM (The Institut national de la santé et de la recherche médicale), Paris, France</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Krutika Kuppali</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>5Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Palo Alto, CA, USA</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Nicola Low</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>6 Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Sara Loree</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>7 The Global Outbreak Alert and Response Network (GOARN), Geneva, Switzerland</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Alasdair Munro</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>8 NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK 9 Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, Hampshire, UK</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Lina Moses</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>7 The Global Outbreak Alert and Response Network (GOARN), Geneva, Switzerland</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Harish Nair</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>10 Centre for Global Health, Usher Institute, University of Edinburgh, Edinburgh, UK</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Piero Olliaro</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>3 ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Louise Sigfrid</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>3 ISARIC Global Support Centre, Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, UK</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>Renaud Vatrinet</foaf:name>
        <org:memberOf>
          <foaf:Organization>
            <foaf:name>4INSERM (The Institut national de la santé et de la recherche médicale), Paris, France</foaf:name>
          </foaf:Organization>
        </org:memberOf>
      </rdf:Description>
    </dct:creator>
    <dct:creator>
      <rdf:Description>
        <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/>
        <foaf:name>on behalf of the CORRE Network (International COVID-19 Rapid Evidence Reviews Group)</foaf:name>
      </rdf:Description>
    </dct:creator>
    <dct:title>An open letter to Oran and Topol, and the Annals of Internal Medicine</dct:title>
    <dct:publisher>
      <foaf:Agent>
        <foaf:name>Zenodo</foaf:name>
      </foaf:Agent>
    </dct:publisher>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2020</dct:issued>
    <dcat:keyword>asymptomatic infections</dcat:keyword>
    <dcat:keyword>SARS-CoV-2</dcat:keyword>
    <dcat:keyword>COVID-19</dcat:keyword>
    <dcat:keyword>systematic review</dcat:keyword>
    <dcat:keyword>evidence synthesis</dcat:keyword>
    <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2020-06-10</dct:issued>
    <owl:sameAs rdf:resource="https://zenodo.org/record/3888361"/>
    <adms:identifier>
      <adms:Identifier>
        <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/3888361</skos:notation>
        <adms:schemeAgency>url</adms:schemeAgency>
      </adms:Identifier>
    </adms:identifier>
    <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.3888341"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/covid-19"/>
    <dct:isPartOf rdf:resource="https://zenodo.org/communities/zenodo"/>
    <owl:versionInfo>version 1</owl:versionInfo>
    <dct:description>&lt;p&gt;An open letter to Oran and Topol, authors of&amp;nbsp;&lt;/p&gt; &lt;p&gt;&lt;strong&gt;&amp;ldquo;Presence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review&amp;rdquo; Annals of Internal Medicine. 2020 June 3. https://doi.org/10.7326/M20-3012&lt;/strong&gt;&lt;/p&gt; &lt;p&gt;and Christine Laine (editor-in-chief The Annals of Internal Medicine)&lt;/p&gt; &lt;p&gt;There is a need to better understand the contribution of asymptomatic SARS-CoV-2 infections (those with no symptoms at all throughout the infection) in driving the current pandemic. However, there are caveats that in our opinion are pertinent when interpreting the reported findings of this review, including the lack of a clear definition of asymptomatic infection and selective inclusion of cross-sectional studies. In addition, there is a problematic interpretation of a narrative review containing a dearth of poor-quality evidence resulting in an overestimate of asymptomatic infections, which might misinform policy response.&lt;/p&gt;</dct:description>
    <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/>
    <dct:accessRights>
      <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess">
        <rdfs:label>Open Access</rdfs:label>
      </dct:RightsStatement>
    </dct:accessRights>
    <dcat:distribution>
      <dcat:Distribution>
        <dct:license rdf:resource="https://creativecommons.org/licenses/by/4.0/legalcode"/>
        <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.3888361"/>
      </dcat:Distribution>
    </dcat:distribution>
    <dcat:distribution>
      <dcat:Distribution>
        <dcat:accessURL>https://doi.org/10.5281/zenodo.3888361</dcat:accessURL>
        <dcat:byteSize>255178</dcat:byteSize>
        <dcat:downloadURL>https://zenodo.org/record/3888361/files/Open letter to Oran and Topol and the Annals of Internal Medicine.pdf</dcat:downloadURL>
        <dcat:mediaType>application/pdf</dcat:mediaType>
      </dcat:Distribution>
    </dcat:distribution>
  </rdf:Description>
</rdf:RDF>
7,468
3,727
views
downloads
All versions This version
Views 7,4684,559
Downloads 3,7272,610
Data volume 942.4 MB666.0 MB
Unique views 6,5624,050
Unique downloads 3,4352,456

Share

Cite as